| Investor Type | Firm |
| Stages | Series B, Series A, Series C |
| Investment Range | $10,000,000 - $191,000,000 |
Marea Therapeutics is a clinical-stage biotechnology firm that uses the most recent advancements in human genetics to create first-in-class, next-generation medications for cardiometabolic illnesses.

